NCT05739721

Brief Summary

Participants (random) will have a conversation with each other over zoom initially with their cameras off and then rate each other on attractiveness, first impressions, and self-esteem. Then both participants will turn their cameras back on and have another conversion and then again rate each other. The ratings are confidential and will not be shared with the other person. Two months later the participants will come to the study clinic office and have an in-person conversation with someone new and rate each other.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Nov 2021

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2021

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

April 19, 2022

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2022

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2022

Completed
4 months until next milestone

First Posted

Study publicly available on registry

February 22, 2023

Completed
Last Updated

February 22, 2023

Status Verified

February 1, 2023

Enrollment Period

11 months

First QC Date

April 19, 2022

Last Update Submit

February 13, 2023

Conditions

AttractivenessSelf EsteemFirst Impressions

Outcome Measures

Primary Outcomes (3)

  • First Impressions

    The defined categories of first impressions include: Social skills, academic performance, dating success, occupational success, attractiveness, financial success, relationship success, and athletic success. The scale ranges from a score of 1 (less desirable) to 10 (most desirable). Scores closer to 10 signify a more positive outcome.

    8 weeks

  • Trustworthiness scale

    Scale 0 (disagree) - 7 (agree). Scores closer to 7 signify a more positive outcome.

    8 weeks

  • Overall Attractiveness

    Scale 0 (disagree) - 7 (agree). Scores closer to 7 signify a more positive outcome.

    8 weeks

Secondary Outcomes (1)

  • Self-Esteem

    8 weeks

Study Arms (4)

Zoom meeting (camera off)

EXPERIMENTAL

participants will be randomly assigned to a Zoom (San Jose, CA, USA) video conference meeting with another participant of the opposite gender

Behavioral: AttractivenessBehavioral: Self-EsteemBehavioral: Trustworthiness

In person meeting (blindfolded)

EXPERIMENTAL

Once all subjects have been selected and enrolled in the study, participants will be randomly assigned for an in-person meeting.

Behavioral: AttractivenessBehavioral: Self-EsteemBehavioral: Trustworthiness

Zoom meeting (camera on)

EXPERIMENTAL

participants will be randomly assigned to a Zoom (San Jose, CA, USA) video conference meeting with another participant of the opposite gender

Behavioral: AttractivenessBehavioral: Self-EsteemBehavioral: Trustworthiness

In person meeting (no blindfold)

EXPERIMENTAL

Once all subjects have been selected and enrolled in the study, participants will be randomly assigned for an in-person meeting.

Behavioral: AttractivenessBehavioral: Self-EsteemBehavioral: Trustworthiness

Interventions

AttractivenessBEHAVIORAL

Visual attractiveness scale 0-7

In person meeting (blindfolded)In person meeting (no blindfold)Zoom meeting (camera off)Zoom meeting (camera on)
Self-EsteemBEHAVIORAL

Self Esteem scale

In person meeting (blindfolded)In person meeting (no blindfold)Zoom meeting (camera off)Zoom meeting (camera on)
TrustworthinessBEHAVIORAL

Trustworthiness scale 0-7

In person meeting (blindfolded)In person meeting (no blindfold)Zoom meeting (camera off)Zoom meeting (camera on)

Eligibility Criteria

Age21 Years - 39 Years
Sexall(Gender-based eligibility)
Gender Eligibility Details20 participants that identify as male and 20 participants that identify as female
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Males and females of ages 21-39.
  • Subjects that understand the purpose and aspects of the study, freely sign the consent and complete the required treatment and follow up visit.
  • Subjects must all be able to speak English fluently.
  • Subjects must have access to video camera technology.
  • Fully Vaccinated against covid-19

You may not qualify if:

  • Participants younger than 21 or older than 40 will not be included.
  • Subjects who are pregnant or nursing.
  • Imprisoned populations.
  • Subjects who are unable to travel to the clinic.
  • Subjects that do not understand the purpose and aspects of the study, do not sign the consent and do not complete the required virtual session and follow-up visit will also be excluded.
  • Any subject that is not fully vaccinated against covid-19

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

DeNova Research

Chicago, Illinois, 60611, United States

Location
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Doctor of Medicine, Principal Investigator

Study Record Dates

First Submitted

April 19, 2022

First Posted

February 22, 2023

Study Start

November 1, 2021

Primary Completion

October 1, 2022

Study Completion

November 1, 2022

Last Updated

February 22, 2023

Record last verified: 2023-02

Locations

US(1)